Press Releases 2015
New data presented at EuroPCR 2015 demonstrate strong performance of the SYNERGY™ Bioabsorbable Polymer stent System over four years - May 19, 2015
Boston Scientific (NYSE: BSX) reported positive, long-term data from the EVOLVE Trial of the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System ...
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com